Exosens SAS (EXENS)

Currency in EUR
63.30
+0.10(+0.16%)
Real-time Data·
Advertisement
EXENS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
61.8063.55
52 wk Range
36.2074.00
Key Statistics
Prev. Close
63.2
Open
61.95
Day's Range
61.8-63.55
52 wk Range
36.2-74
Volume
20.82K
Average Volume (3m)
94.5K
1-Year Change
48.7662%
Book Value / Share
8.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXENS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
67.23
Upside
+6.21%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Exosens SAS News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

8 Buy
2 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 67.23
(+6.21% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy73.00+15.32%71.00Maintain04/08/2026
Kepler Cheuvreux
Buy66.50+5.06%-Upgrade20/07/2026
Berenberg
Buy72.00+13.74%69.00Maintain28/04/2026
Deutsche Bank
Hold60.00-5.21%55.00Maintain15/04/2026
Kepler Cheuvreux
Hold66.50+5.06%47.20Maintain03/03/2026

Exosens SAS Earnings Call Summary for Q2/2025

  • Exosens reported 20% YoY revenue growth to €224.5M in H1 2025, with adjusted EBITDA up 24% to €69.5M
  • Stock rose 2.7% post-earnings, trading near 52-week high of $60.48; company projects high teens revenue growth for 2025
  • 5G night vision technology launch set for September; new US manufacturing facility planned to expand production capacity
  • Strong performance driven by defense market expansion in NATO countries and focus on night vision and imaging technologies
  • Company maintains positive outlook, targeting selective M&A and sustaining leverage ratio around 2x
Last Updated: 14/10/2025, 23:16
Read Full Transcript

Earnings

Latest Release
28/07/2026
EPS / Forecast
0.30 / --
Revenue / Forecast
130.5M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.60%
Dividend Yield
0.47%
Industry Median 1.35%
Annualised payout
0.30
Paid annually
5-Years Growth
-
Growth Streak

Exosens (EXENS) Income Statement & Profits

Compare EXENS to Peers and Sector

Metrics to compare
EXENS
Peers
Sector
Relationship
P/E Ratio
57.1x36.6x12.3x
PEG Ratio
−1.250.910.03
Price/Book
7.1x6.0x1.4x
Price / LTM Sales
6.4x2.4x1.2x
Upside (Analyst Target)
5.8%13.8%25.1%
Fair Value Upside
Unlock−9.3%6.8%Unlock

Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and components, such as phosphor screens, resistive glass products, microchannel plates, and electron generator arrays. It also provides bare and energy compensated Geiger- Müller tubes; gamma and neutron detectors; mineral insulated extensions; and silicon photodiodes, as well as methane airborne detection solutions. The company sells its products under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brand names. It serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. The company was founded in 1937 and is headquartered in Mérignac, France.

Employees
2000
Market
France

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
15.61M30.79%986.48M
Other Institutional Investors
19.22M37.90%1.21B
Public Companies & Retail Investors
15.87M31.31%1.00B
Total
50.7M100.00%3.2B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
HLD Europe S.C.A.14.14%7,169,880453,136
Venetus Limited9.82%4,975,806314,471

People Also Watch

33.50
NANOB
-1.41%
26.65
LBIRD
0.00%
24.80
ELIS
-0.96%
44.00
ALSEM
+3.17%
9.49
DBG
-0.32%

FAQ

What Is the Exosens (Paris: EXENS) Share Price Today?

The Exosens stock price today is 63.30 EUR.

What Stock Exchange Does Exosens (EXENS) Trade On?

Exosens is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Exosens?

The stock symbol (also called a 'ticker') for Exosens is "EXENS."

Does Exosens Pay Dividends? What’s The Current EXENS Dividend Yield?

Yes, EXENS Pays Dividends to its Shareholders. The current Exosens dividend yield is 0.48%.

What Is the Current Exosens Market Capitalisation?

As of today, Exosens (Paris: EXENS) market cap is 3.22B EUR.

What Is Exosens's (EXENS) Earnings Per Share (TTM)?

The Exosens EPS is currently 0.60 (Trailing Twelve Months).

When Is the Next Exosens Earnings Date?

Exosens's next earnings report will be released on 27/10/2026.

Is EXENS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Exosens moving averages and other technical indicators, the daily buy/sell signal for EXENS stock is Strong Buy.

How Many Times Has Exosens Stock Split?

Exosens has split 0 times. (See the EXENS stock split history page for full effective split date and price information.)

How Many Employees Does Exosens Have?

Exosens has 2000 employees, based on their latest Companies House report.

What is the current trading status of Exosens (Paris: EXENS)?

As of 06/08/2026, Exosens (EXENS) is trading at a share price of 63.30 EUR, with a previous close of 63.20 EUR. The stock has fluctuated within a day range of 61.80 EUR to 63.55 EUR, while its 52-week range spans from 36.20 EUR to 74.00 EUR.

What Is Exosens (EXENS) Price Target According to Analysts?

The average 12-month price target for Exosens is 67.23 EUR, with a high estimate of 75 EUR and a low estimate of 59.3 EUR. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +6.21% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.